Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › 13vPnC

13vPnC

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of 13vPnC

13 trials tracked of 13vPnC: 11 in phase 3 or 4 and 6 with published results. The most-cited published study has 171 citations.

13Trials tracked
11Phase 3 & 4
0Recruiting
6With published results
Phase distribution
Phase 4 2 Phase 3 9 Phase 2 1 Phase 1 1
  1. Phase 3 Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults Completed · 171 cited
  2. Phase 3 Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination Completed · 82 cited
  3. Phase 3 Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults Completed · 77 cited
  4. Phase 3 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan Completed · 22 cited
  5. Phase 4 Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In India Completed · 7 cited
  6. Phase 3 A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children Completed · 4 cited
Show 7 more trials
  1. Phase 4 Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India Completed
  2. Phase 3 Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Completed
  3. Phase 3 Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Adults Aged >= 50 Years Completed
  4. Phase 3 Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Children Completed
  5. Phase 3 Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants Completed
  6. Phase 2 Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants Completed
  7. Phase 1 Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.